CAM use in cancer patients risky

Research presented today at the Clinical Oncology Society of Australia (COSA) annual scientific meeting in Melbourne reveals that some of the most popular complementary remedies have predicted or actual drug interactions when taken with chemotherapy, radiation therapy or before surgery.

Senior pharmacist at the Peter MacCallum Cancer Centre and lead researcher on the study, Sally Brooks, said the use of CAM in the cancer population is much higher than the general population with some studies estimating use to be as high as 70%.